SMS Pharmaceuticals Q4 Results

  • BSE: 532815
  • NSE: SMSPHARMA
  • ISIN: INE812G01025
  • Sector: Biotechnology & Drugs
BSE
203.05-0.50 (-0.25%)
Volume36.53 K
Updated: Thu 23 May, 2024 | 15:29:59
NSE
201.25-2.25 (-1.11%)
Volume1.47 L
Updated: Thu 23 May, 2024 | 15:44:20
Today: 200.60
209.90
52-Wk: 75.10
219.30

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - SMS Pharmaceuticals Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 23Dec 22QoQ Comp
    Total Revenue 149.43148.800.42%
    Selling/ General/ Admin Expenses Total 15.7813.5716.31%
    Depreciation/ Amortization 7.978.12-1.85%
    Other Operating Expenses Total 7.204.8149.56%
    Total Operating Expense 134.60138.41-2.75%
    Operating Income 14.8210.3942.66%
    Net Income Before Taxes 10.196.6752.87%
    Net Income 3.513.76-6.74%
    Diluted Normalized EPS 0.410.44-6.06%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumFor youGet App